By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovoCure Ltd. 



Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Medical Device






Company News
NovoCure Announces Departure Of Chief Commercial Officer 2/23/2017 7:49:29 AM
NovoCure Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Company Update 2/23/2017 6:38:36 AM
First Patient Enrolled In NovoCure’s Phase III Pivotal LUNAR Trial Testing Tumor Treating Fields For The Treatment Of Advanced Non-Small Cell Lung Cancer After Failing Platinum-Based Therapy 2/15/2017 6:26:02 AM
NovoCure Release: Company’s Optune Now Available At 500 Cancer Treatment Centers In The U.S. 1/19/2017 8:58:37 AM
NovoCure Release: Company To Report Fourth Quarter And Full Year 2016 Financial Results 1/10/2017 11:45:26 AM
NovoCure Rlease: Pharma Announces Preliminary Fourth Quarter And Full Year 2016 Operating Statistics 1/10/2017 11:42:22 AM
NovoCure’s Optune (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma 12/19/2016 9:54:52 AM
NovoCure Presents Second Cohort Of Phase 2 Pilot PANOVA Trial Results Suggesting Tumor Treating Fields Plus Nab-Paclitaxel And Gemcitabine May Be Safe As First-Line Treatment And May Improve One-Year Survival Rate Of Patients With Advanced Pancreatic Cancer 12/13/2016 11:44:17 AM
NovoCure Presents Phase 2 Pilot INNOVATE Trial Results Suggesting Tumor Treating Fields Plus Paclitaxel May Be Safe As First-Line Treatment And May Improve Survival Of Patients With Recurrent Ovarian Cancer 12/13/2016 11:42:46 AM
Long-Term Analysis Of All 695 Patients Enrolled In NovoCure’s Phase 3 Pivotal Trial In Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results And Demonstrates Superior Two- And Four-Year Survival Rates 11/18/2016 11:42:05 AM
12345678910...
//-->